Chronic hepatitis D coinfection affects an estimated 12 million people globally, with higher prevalence in low-income and middle-income countries, especially the African and Western Pacific regions.

Chronic hepatitis D virus (HDV) coinfection in people with chronic hepatitis B is associated with rapid progression to liver cirrhosis and high mortality. In 2020, the estimated global HDV burden ...

This article was reviewed by Darragh O’Carroll, MD. Pros, Cons & Benefits of At-Home Lab Testing You probably don’t have time (or want to) to sit … ...

Detailed price information for Atea Pharmaceuticals Inc (AVIR-Q) from The Globe and Mail including charting and trades.

Advanced Global Phase 3 Program for Treatment of Hepatitis C Virus (HCV) in 2025 with Topline Results from North American C-BEYOND Trial Expected Mid-2026 and Topline Results from C-FORWARD Trial Outs ...

Management emphasized that both pivotal Phase III HCV trials are open-label, randomized, and structured for regulatory alignment with FDA and EMA requirements. New data presented at recent conferences ...

Advanced Global Phase 3 Program for Treatment of Hepatitis C Virus (HCV) in 2025 with Topline Results from North American C-BEYOND Trial Expected Mid-2026 and Topline Results from C-FORWARD Trial Outs ...

Adding laboratory-based HIV viral load (VL) test results — with a median turnaround time of 26 hours — to standard-of-care testing did not improve overall linkage to care compared with ...

More photos from the Rodeo Rapid City 20X SD High School Showcase Featuring competitors from Box Elder, Buffalo, Creighton, Dupree, Faith, Martin, New Underwood, St. Onge, Sturgis, Wall, Whitewood and ...

PHOENIX — A new rapid test for Valley Fever developed in Phoenix is getting ready to go on the market and will be a game-changer for doctors in diagnosing the disease. Valley Fever is a disease that ...

The 15-minute time-to-result qualitative molecular test for hepatitis C virus was able to detect HCV genotypes 1 to 6 at a detection limit of 200 IU/mL with the addition of 100 µL of specimen volume.

Assay demonstrated 100 percent positive percent agreement and negative percent agreement compared with commercial platforms. HealthDay News — A rapid, highly accurate test has been developed for ...